ZA931035B - Sulfonic acid derivatives in the treatment of viral diseases. - Google Patents

Sulfonic acid derivatives in the treatment of viral diseases.

Info

Publication number
ZA931035B
ZA931035B ZA931035A ZA931035A ZA931035B ZA 931035 B ZA931035 B ZA 931035B ZA 931035 A ZA931035 A ZA 931035A ZA 931035 A ZA931035 A ZA 931035A ZA 931035 B ZA931035 B ZA 931035B
Authority
ZA
South Africa
Prior art keywords
sulfonic acid
treatment
acid derivatives
viral diseases
viral
Prior art date
Application number
ZA931035A
Other languages
English (en)
Inventor
Alan D Cardin
Norton P Peet
Nelsen L Lentz
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of ZA931035B publication Critical patent/ZA931035B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02—Monothiocarbonic acids; Derivatives thereof
    • C07C329/04—Esters of monothiocarbonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/12—Dithiocarbonic acids; Derivatives thereof
    • C07C329/14—Esters of dithiocarbonic acids
    • C07C329/20—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/08—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C07C333/24—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA931035A 1992-02-20 1993-02-15 Sulfonic acid derivatives in the treatment of viral diseases. ZA931035B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83863992A 1992-02-20 1992-02-20

Publications (1)

Publication Number Publication Date
ZA931035B true ZA931035B (en) 1993-09-17

Family

ID=25277670

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931035A ZA931035B (en) 1992-02-20 1993-02-15 Sulfonic acid derivatives in the treatment of viral diseases.

Country Status (15)

Country Link
US (1) US5359131A (xx)
EP (1) EP0626945B1 (xx)
JP (1) JP3309104B2 (xx)
KR (1) KR100275843B1 (xx)
AT (1) ATE165345T1 (xx)
AU (1) AU663925B2 (xx)
CA (1) CA2130360C (xx)
DE (1) DE69318136T2 (xx)
ES (1) ES2115756T3 (xx)
IL (1) IL104780A (xx)
MX (1) MX9300836A (xx)
NZ (1) NZ249032A (xx)
TW (1) TW224968B (xx)
WO (1) WO1993016992A1 (xx)
ZA (1) ZA931035B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
WO1996025157A1 (en) 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
US5681832A (en) * 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
BR9612004A (pt) * 1995-12-15 1999-12-28 Cryopreservation Thechnologies Composição para criopreservação de orgão e tratamento de infecções virais e bacterianas
US5852015A (en) * 1997-01-27 1998-12-22 American Cyanamid Company Triazine containing anionic compounds useful as antiviral agents
CN1163401A (zh) * 1996-02-13 1997-10-29 李占元 全自动血球计数仪试剂及配制方法
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
TR199802695T2 (xx) 1996-06-27 1999-04-21 Smithkline Beecham Corporation IL-8 Resept�r kar��tlar�
TR199802694T2 (xx) * 1996-06-27 1999-03-22 Smithkline Beecham Corporation IL-8 resept�r kar��tlar�
ZA984649B (en) * 1997-06-13 1999-12-17 Cryopreservation Tech Cc "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
GB9928418D0 (en) * 1999-12-01 2000-01-26 Novartis Ag Organic compounds
US6806366B2 (en) 2001-02-02 2004-10-19 Wyeth Preparation and purification of antiviral disulfonic acid disodium salt
JP2007523073A (ja) * 2004-02-04 2007-08-16 アクテイブ・バイオテツク・アクテイエボラーグ ジウレア誘導体
BRPI0713792A8 (pt) * 2006-06-27 2018-01-09 Hadasit Medical Res Services And Development Limited uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos
CA2671900A1 (en) * 2006-12-22 2008-07-03 The Regents Of The University Of California Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
WO2010148177A2 (en) * 2009-06-17 2010-12-23 The Board Of Trustees Of The Leland Stanford Junior University Compounds, compositions, methods of synthesis, and methods of treatment
TW201702218A (zh) * 2014-12-12 2017-01-16 美國杰克森實驗室 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法
JP2022514195A (ja) * 2018-11-22 2022-02-10 ユニバーシテ デ ナンテス 増殖性疾患の処置で使用するためのジスルホナートスチルベン

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD39717A (xx) *
US2676982A (en) * 1951-06-08 1954-04-27 Gen Aniline & Film Corp Fluorescent agents
BE660945A (xx) * 1964-03-12 1965-07-01
US4107202A (en) * 1977-03-28 1978-08-15 American Cyanamid Company Substituted 4,4'-biphenylylene bis(2-thioureylene)di-naphthalenetrisulfonic acids and salts thereof
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
DE3528992A1 (de) * 1985-08-13 1987-02-26 Barthell Eduard Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung
DE3600046A1 (de) * 1985-08-13 1987-07-09 Barthell Eduard Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung
DE3530718A1 (de) * 1985-08-28 1987-03-12 Madaus & Co Dr Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten
EP0221021B1 (en) * 1985-10-16 1989-11-08 Ciba-Geigy Ag Bechamp reduction of dns to das using h2so4 and trace of hoac
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
DE69106493T2 (de) * 1991-02-05 1995-06-29 Merrell Dow Pharma Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.

Also Published As

Publication number Publication date
AU3481893A (en) 1993-09-13
NZ249032A (en) 1996-09-25
MX9300836A (es) 1993-09-01
ATE165345T1 (de) 1998-05-15
JP3309104B2 (ja) 2002-07-29
US5359131A (en) 1994-10-25
DE69318136T2 (de) 1998-10-22
ES2115756T3 (es) 1998-07-01
TW224968B (xx) 1994-06-11
IL104780A (en) 1998-10-30
KR950700245A (ko) 1995-01-16
AU663925B2 (en) 1995-10-26
IL104780A0 (en) 1993-06-10
JPH07504190A (ja) 1995-05-11
CA2130360C (en) 1998-06-09
EP0626945B1 (en) 1998-04-22
CA2130360A1 (en) 1993-08-21
WO1993016992A1 (en) 1993-09-02
DE69318136D1 (de) 1998-05-28
EP0626945A1 (en) 1994-12-07
KR100275843B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
IL104780A0 (en) Sulfonic acid derivatives in the treatment of viral diseases
AU1062092A (en) Sulfonic stilbene derivatives in the treatment of viral diseases
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
NO985200L (no) Antimikrobiell behandling for herpes simplex virus, og andre infeksi÷se syk
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
GB2244646B (en) Anti-viral agents comprising a poly(ADP-ribose) polymerase inhibitor
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE3776999D1 (de) Mittel zur vorbeugung gegen pflanzenviruskrankheiten.
ES544787A0 (es) Preparaciones medicinales solidas
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
NO881629L (no) Anvendelse av antigene stoffer ved behandling av lidelseri mage-tarm-kanalen.
DK3689D0 (da) Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsvaekkere i blodplasmaprodukter
DK147088D0 (da) Middel til behandling af virale infektioner i mennesker
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
GB2179858B (en) Compositions for treating viral skin diseases.
NO903801L (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
IE820661L (en) Carnitines
IT1187642B (it) Emoglobina a ridotti rischi da virus e procedimento per prepararla
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours